Federal court upholds FDA off-label regulations

A federal court has ruled that FDA's policies on the dissemination of information about unapproved (off-label) uses of approved products are legal, but he also said they provide

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE